Serum SEMA3A was decreased in patients with systemic lupus erythematosus (SLE) and was increased in patients with rheumatoid arthritis and Sjogren’s syndrome, suggesting the important role of SEMA3A in immune-related diseases [25]. This evidence concerns the gene SEMA3A and systemic lupus erythematosus.